Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Companies

This report lists the top Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor industry.

Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Top Companies

  1. AstraZeneca

  2. Eli Lilly and Company

  3. Astellas Pharma

  4. Bristol-Myers Squibb

  5. Janssen

*Disclaimer: Top companies sorted in no particular order

Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market Major Players

Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market Concentration

Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market Concentration

Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Company List

  • Eli Lilly

  • Janssen Pharmaceuticals

  • Bristol Myers Squibb

  • Boehringer Ingelheim

  • AstraZeneca

  • Astellas


Specific to Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market
Need More Details on Market Players and Competitors?
Download PDF

Latin America Sodium-Glucose Cotransport-2 Inhibitor Market Report Snapshots

Latin America Sodium-Glucose Cotransport-2 Inhibitor Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)